Your browser doesn't support javascript.
loading
A novel radiomics signature based on T2-weighted imaging accurately predicts hepatic inflammation in individuals with biopsy-proven nonalcoholic fatty liver disease: a derivation and independent validation study.
Chen, Zhong-Wei; Xiao, Huan-Ming; Ye, Xinjian; Liu, Kun; Rios, Rafael S; Zheng, Kenneth I; Jin, Yi; Targher, Giovanni; Byrne, Christopher D; Shi, Junping; Yan, Zhihan; Chi, Xiao-Ling; Zheng, Ming-Hua.
Afiliação
  • Chen ZW; Department of Radiology, the First Affiliated Hospital of Wenzhou Medical University, Wenzhou, China.
  • Xiao HM; Department of Hepatology, Guangdong Provincial Hospital of Chinese Medicine, the Second Affiliated Hospital of Guangzhou University of Chinese Medicine, Guangzhou, China.
  • Ye X; Department of Radiology, the Second Affiliated Hospital and Yuying Children's Hospital of Wenzhou Medical University, Wenzhou, China.
  • Liu K; Department of Radiology, the Second Affiliated Hospital and Yuying Children's Hospital of Wenzhou Medical University, Wenzhou, China.
  • Rios RS; NAFLD Research Center, Department of Hepatology, the First Affiliated Hospital of Wenzhou Medical University, Wenzhou, China.
  • Zheng KI; NAFLD Research Center, Department of Hepatology, the First Affiliated Hospital of Wenzhou Medical University, Wenzhou, China.
  • Jin Y; Department of Pathology, the First Affiliated Hospital of Wenzhou Medical University, Wenzhou, China.
  • Targher G; Section of Endocrinology, Diabetes and Metabolism, Department of Medicine, University and Azienda Ospedaliera Universitaria Integrata of Verona, Verona, Italy.
  • Byrne CD; Southampton National Institute for Health Research Biomedical Research Centre, University Hospital Southampton, Southampton General Hospital, Southampton, UK.
  • Shi J; Department of Hepatology, The Affiliated Hospital of Hangzhou Normal University, Hangzhou, China.
  • Yan Z; Department of Radiology, the Second Affiliated Hospital and Yuying Children's Hospital of Wenzhou Medical University, Wenzhou, China.
  • Chi XL; Department of Hepatology, Guangdong Provincial Hospital of Chinese Medicine, the Second Affiliated Hospital of Guangzhou University of Chinese Medicine, Guangzhou, China.
  • Zheng MH; NAFLD Research Center, Department of Hepatology, the First Affiliated Hospital of Wenzhou Medical University, Wenzhou, China.
Hepatobiliary Surg Nutr ; 11(2): 212-226, 2022 Apr.
Article em En | MEDLINE | ID: mdl-35464279

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Tipo de estudo: Prognostic_studies / Risk_factors_studies Idioma: En Revista: Hepatobiliary Surg Nutr Ano de publicação: 2022 Tipo de documento: Article País de afiliação: China País de publicação:

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Tipo de estudo: Prognostic_studies / Risk_factors_studies Idioma: En Revista: Hepatobiliary Surg Nutr Ano de publicação: 2022 Tipo de documento: Article País de afiliação: China País de publicação: